Nilai Buku saben Saham: Skye Bioscience (SKYE)

Skye Bioscience, Inc. (SKYE) management is currently actively pivoting its strategy toward the weight loss drug market, which is fueling shareholder optimism. The business relies on external contractors for testing and product promotion. This daily price action on the GURU.Markets platform, visualized for analytical convenience, is currently at -0.11. Meanwhile, drug manufacturing has been outsourced to third-party plants, while the company's own laboratories remain in California.

Ekuitas saben Saham skyebioscience.com (SKYE): kanggo periode 12.04.2024 - 28.10.2026

Ringkesan rincian data analitis skyebioscience.com (SKYE)

- rega lan prakiraan konsensus rega:

Kutipan saham Skye Bioscience, Inc.|SKYE - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Kapitalisasi pasar Skye Bioscience, Inc.|SKYE - Total Nilai Perusahaan

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Skye Bioscience|SKYE - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku skyebioscience.com|SKYE - Total Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas Skye Bioscience, Inc.|SKYE - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Skye Bioscience|SKYE - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Skye Bioscience, Inc.

Pambiji fundamental perusahaan:Skye Bioscience, Inc., SKYE

Skye Bioscience, Inc. (SKYE) focuses on creating unique cannabinoid modifications to combat obesity, protecting its developments through FDA patents. The bps metric trend reflects the ratio of net equity to the number of shares, allowing for a real-time assessment of the actual asset value per share and the identification of hidden imbalances in the company's asset structure prior to the publication of official reports.

Analisis pesaing